Molina Healthcare (NYSE:MOH) Price Target Raised to $372.00 at Barclays

Molina Healthcare (NYSE:MOH) had its target price lifted by equities researchers at Barclays from $359.00 to $372.00 in a report issued on Friday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 14.27% from the company’s current price.

Several other equities analysts have also recently weighed in on MOH. Wells Fargo & Company raised their target price on shares of Molina Healthcare from $315.00 to $360.00 and gave the company an “equal weight” rating in a research note on Monday, August 5th. Jefferies Financial Group reduced their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a report on Wednesday, July 24th. Robert W. Baird dropped their price target on Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating for the company in a research note on Thursday. JPMorgan Chase & Co. reduced their price objective on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. One analyst has rated the stock with a sell rating, six have given a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $367.00.

Molina Healthcare Price Performance

NYSE:MOH opened at $325.54 on Friday. The business’s 50-day simple moving average is $335.23 and its two-hundred day simple moving average is $329.72. Molina Healthcare has a 52 week low of $272.69 and a 52 week high of $423.92. The stock has a market cap of $19.08 billion, a PE ratio of 17.84, a P/E/G ratio of 0.99 and a beta of 0.58. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.05. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company had revenue of $10.34 billion for the quarter, compared to the consensus estimate of $9.92 billion. During the same quarter last year, the company earned $5.05 EPS. The firm’s quarterly revenue was up 21.0% on a year-over-year basis. As a group, analysts forecast that Molina Healthcare will post 23.5 EPS for the current fiscal year.

Insider Activity

In related news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Several large investors have recently added to or reduced their stakes in MOH. Innealta Capital LLC purchased a new position in shares of Molina Healthcare during the second quarter worth approximately $36,000. Ashton Thomas Private Wealth LLC bought a new stake in Molina Healthcare during the 2nd quarter valued at $40,000. AM Squared Ltd bought a new stake in Molina Healthcare during the 2nd quarter valued at $59,000. UMB Bank n.a. lifted its holdings in shares of Molina Healthcare by 96.2% in the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after buying an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC bought a new position in shares of Molina Healthcare during the 1st quarter worth $151,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.